ALS patient registry in Thailand
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study will create a registry of people with ALS in Thailand. The goal is to track the disease and to improve the care and treatment for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ALS by a doctor using specific guidelines.
- You are 18 years old or older.
- You are able and willing to give your permission to be in the study.
- You do not have a different condition that looks like ALS.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the biology of amyotrophic lateral sclerosis (ALS) to better understand the disease. If you are a patient of Dr. Espíndola at UFSC, you may be able to join.
This study screens people with ALS to see if they might qualify for future gene-targeted treatments. It helps match you to trials that may be a good fit for your genetic type.
This study is looking for biological markers in the blood that can help monitor how ALS progresses and potentially detect it earlier. By participating, you may help improve future diagnosis and care for ALS patients.
This study is a research collaborative that collects information from people with ALS or their families. It aims to better understand the disease and find markers that could help develop treatments.
This trial is a registry that collects information from adults with ALS who are using traditional Chinese medicine. It may help researchers better understand ALS and how traditional treatments are used alongside standard care.
This study is a national registry that collects information from people with amyotrophic lateral sclerosis (ALS) to better understand the disease. Joining may help researchers learn about patterns of symptoms and care over time.
Hear when a new ALS (Amyotrophic Lateral Sclerosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.